1-3 of 3
Christian Müller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incorporation of the Bone Marker Carboxy-Terminal Telopeptide of Type-1 Collagen (ICTP) into a Combined ISS-ICTP Score Improves the Prognostic Significance of the ISS in Newly Diagnosed Symptomatic Multiple Myeloma and Identifies a Very Low Risk Group Which Has No Benefit from High-Dose Therapy

Christian Jakob, MD, Peter Liebisch, MD, Ulrike Heider, MD, Martin Kaiser, MD, Jan Sterz, MD, Jessica Rademacher, MD, Claudia Fleissner, MD, Christian Müller, MD, Orhan Sezer, MD
Journal: Blood
Blood (2008) 112 (11): 2721.
https://doi.org/10.1182/blood.V112.11.2721.2721
Published: 2008
Journal Articles

Treatment of Bortezomib Increases Osteoblast Function in Patients with Multiple Myeloma.

Ulrike Heider, MD, Martin Kaiser, MD, Christian Müller, MD, Carsten-Oliver Schulz, MD, Christian Jakob, MD, Ivana Zavrski, MD, Jan Eucker, MD, Jan Sterz, MD, Lorenz Kleeberg, MD, Kurt Possinger, MD, Orhan Sezer, MD
Journal: Blood
Blood (2005) 106 (11): 3457.
https://doi.org/10.1182/blood.V106.11.3457.3457
Published: 2005
Journal Articles

Oral isobutyramide reduces transfusion requirements in some patients with homozygous β-thalassemia

Clinical Trials & Observations
Susanne Reich, Christoph Bührer, Günter Henze, Dieter Ohlendorf, Michael Mesche, Pranav Sinha, Andreas Kage, Christian Müller, Barbara Vetter, Andreas E. Kulozik
Journal: Blood
Blood (2000) 96 (10): 3357–3363.
https://doi.org/10.1182/blood.V96.10.3357
Published: 2000